content top

Two Different Options in the Treatment of Premacular Hemorrhage Secondary to Macroaneurysm

  SCIENTIFIC POSTER_Ines Coutinho Purpose: Premacular hemorrhage is one major cause of sudden visual loss and occurs in a variety of disorders, among others in retinal arterial macroaneurysms (RAM). Possible therapeutic options include observation, vitrectomy, intravitreal rT-PA injection or laser posterior hyaloidotomy. However, the best treatment is still controversial. We report on 2 cases with premacular haemorrhage due to RAM. The...

Read More

Surgical Approach to Massive Subretinal Hemorrhages Secondary to Neovascular ARMD

Purpose: Different surgical management of massive subretinal hemorrhage secondary to ARMD will be defined. Methods: Pars plana vitrectomy (PPV) with 360 retinotomy and removal of subretinal hemorrhage and membrane +/- choroidal patch graft is performed to 3 cases of massive subretinal hemorrhage secondary to ARMD and the results and surgical videos will be presented. Take home message: Subretinal surgery is unavoidable in such cases to...

Read More

PPV, Subretinal Injection of TPa and Intraocular Gas Tamponade for Thick Submacular Hemorrhage with ARMD

Advantages: To evaluate the safety and efficacy of pars plana vitrectomy, subretinal injection of tissue plasminogen activator (tPA) and intraocular gas tamponade for thick submacular hemorrhage caused by age-related macular degeneration. Methods: The authors reviewed the medical records of 16 consecutive patients who underwent pars plana vitrectomy, subretinal tPA (25ug/0.1ml) injection with 20% SF6 gas. The main outcome measures were...

Read More

Treatment of Submacular Hemorrhages from Macular Degeneration – One More Option

http://www.evrs.eu/medias/2010/congress/Hemorrhages.flv Ivan Tanev (Sofia, Bulgaria) Advantages: Sub-macular hemorrhage (SMH) is one of the most common complications of the neovascular age related macular degeneration (AMD). Eyes with large sub-retinal hemorrhages arising from exudative macular degeneration have a poor prognosis due to progressive fibrosis and organization of the sub-retinal clot.  Early removal of the sub-retinal blood...

Read More

Intravitreal Injection of Tissue Plasminogen Activator (TPA) and Gas C3F8 for the Management of Large Submacular Hemorrhage

Evangelia Papavasileiou, S. Liazos, Timothy Jackson (London, UK) Advantages: To describe the safety and efficacy of intravitreal TPA and C3F8 for the management of extensive sub macular hemorrhages (SMH), associated with AMD related choroidal neovascularisation (CNV) or Idiopathic Polypoidal Choroidal Vasculopathy (IPCV). Methods: Consecutive case series of 7 patients, presenting with acute SMH from neovascular AMD (N = 5) and IPCV (N =...

Read More

Risk Factors for Recurrent Submacular Hemorrhage in Neovascular, Age-Related Macular Degeneration

June-Gone Kim, Sung Jae Yang, Jong Uk Hwang, Soo Geun Joe, Joo Yong Lee (Seoul, South Korea) Advantages: To describe the clinical characteristics and risk factors of recurrent, submacular hemorrhage in AMD. Methods: We reviewed the medical records of the neovascular AMD patients showing submacular hemorrhage at their onset. The required minimum follow-up period was 24 months, and any newly developed, submacular hemorrhage larger than one...

Read More
content top